Contact : (321) 445-1969

Global Allied Pharmaceuticals

Redefining Patient Engagement with Generative AI

About Us

At Global Allied Pharmaceuticals, we are revolutionizing the biopharma and clinical trial landscape through Generative AI (Gen-AI). As the pioneers of AI-driven patient recruitment, engagement, and lifecycle support, we combine cutting-edge technology with patient-centric innovation to deliver unmatched efficiency and outcomes.

Generative AI: The Core of Patient-Centric Innovation

Our solutions are powered by Generative AI, redefining how biopharma companies interact with patients and optimize clinical trials. Through adaptive automation, real-time insights, and personalized engagement, we set a new standard for clinical trial efficiency and patient satisfaction.

What Makes Our Gen-AI Solutions Unique?

  • Dynamic Patient Recruitment: Using Gen-AI to identify, match, and engage patients across diverse populations with unmatched precision.
  • Predictive Adherence Models: Leveraging AI algorithms to anticipate patient needs, reducing dropouts and improving retention.
  • Automated Engagement: AI-powered chatbots and virtual assistants providing personalized, 24/7 support.
  • AI-Driven Insights: Real-world data integration and adaptive protocol design for faster trial optimization.
  • Personalized Interventions: NLP-powered digital education, symptom tracking, and tailored care plans.

End-to-End Patient Lifecycle Solutions Driven by Generative AI

1. AI-Enhanced Patient Recruitment

  • Precision Matching using EHR and claims data powered by advanced NLP.
  • Diversity & Inclusion Outreach driven by AI models that ensure equitable representation.
  • Decentralized Recruitment with telemedicine, geo-targeting, and virtual pre-screening tools.

Case Study: Revolutionizing Oncology Trial Recruitment with Gen-AI

Challenge: A biopharma company struggled with slow patient enrollment and underrepresentation.

Solution: Gen-AI-driven patient identification, multilingual engagement, and automated pre-screening.

Outcome: 35% faster enrollment and 60% improvement in diversity.

2. Retention & Adherence Powered by Gen-AI

  • Predictive Adherence Risk Models to detect and prevent patient dropout.
  • Virtual Patient Assistants providing real-time study reminders, Q&A, and behavioral coaching.
  • IoT-Enabled Home Monitoring for real-time data collection and intervention.
  • Personalized Retention Programs using AI to automate support services and track adherence trends.

Case Study: Enhancing Retention in Rare Disease Trials

Challenge: Patients faced protocol complexity and travel burdens, leading to dropouts.

Solution: Gen-AI-powered virtual assistants and concierge support for adherence tracking.

Outcome: 92% retention rate and 65% improvement in adherence.

3. Post-Market Engagement with Generative AI

  • AI-Powered Hub Services for onboarding, engagement, and adherence tracking.
  • Generative AI-Driven Digital Coaching for continuous, personalized support.
  • Real-World Evidence Collection using AI-driven analytics and safety monitoring.
  • AI Virtual Nurses providing tailored post-treatment care and symptom tracking.

Case Study: Scaling Post-Market Engagement for Biologic Therapies

Challenge: A biopharma company needed scalable patient support after product launch.

Solution: AI-powered hub services for onboarding and automated adherence monitoring.

Outcome: 90% onboarding within 2 weeks and 75% adherence after 6 months.

Why Choose Global Allied Pharmaceuticals?

  • Personalization at Scale: Every patient receives tailored care and real-time support.
  • Smarter Decision-Making: AI-powered insights optimize trial design and execution.
  • Improved Outcomes: Higher retention, better adherence, and faster enrollment.
  • Inclusivity: Advanced AI ensures diversity in recruitment and equitable access to trials.
  • Efficiency: Cost-effective decentralized trials with automated interventions.

Leading the Future of Biopharma with Gen-AI

With 20 years of experience, Global Allied Pharmaceuticals is at the forefront of AI-powered transformation in biopharma.